01-01-1970 12:00 AM | Source: Angel Broking Ltd
Dr.Reddy`s launches Albendazol in US By Mr. Yash Gupta, Angel Broking Ltd
Below are Quote on Dr.Reddy`s launches Albendazol in US by Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd
Dr. Reddy’s Laboratories Ltd. along with its subsidiaries together today announced the launch of Albendazole Tablets, USP, a therapeutic equivalent generic version of Albenza Tablets, 200 mg, approved by the U.S. Food and Drug Administration (USFDA). The Albenza brand and generic had U.S. sales of approximately $27 million MAT for the most recent twelve months ending in November 2020 according to IQVIA Health*. Dr. Reddy’s Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two. Albenza is a trademark of Glaxosmithkline.
This is a positive development for the company but we don’t expect it to make any huge difference on Drreddy top line as product sales in the USA market was less.
Above views are of the author and not of the website kindly read disclaimer
Latest News
J&K: Udhampur wildlife authorities makes arrangement...
Sagarika Ghatge, Zaheer Khan attend brand collab eve...
Daily market commentary : Nifty traded firmly for th...
Allcargo Terminals Q4FY24 Earnings- CFS Volumes Surg...
Record SIPs and AUM Surge : Mutual Funds Bullish on ...
Daily Market Outlook from Vinod Nair, Head of Resear...
Quote on FPI By Dr. V K Vijayakumar ,Geojit Financia...
Quote on FPI from MojoPMS and Waterfield Advisors
Gurugram real estate booms with unprecedented growth...
Perspective on markets by Mr. Jaykrishna Gandhi, Hea...
Tag News
On the higher side, immediate resistance is seen around 36000 - 36200 levels - Angel One
Nifty started the day marginally positive and traded in a range for the first couple of hours - Angel One
Quote on Real-estate sector update By Mr. Yash Gupta, Angel One Ltd
Our markets had a remarkable comeback in last four sessions as we not only managed to recover from lows but also went on to clock fresh highs - Angel One